Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE

Abstract Introduction For chronic diseases such as axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), and plaque psoriasis (PsO), treatment goals include remission or at least low disease activity (LDA) by 12 weeks. Improvements in symptoms such as pain and fatigue should also be treatment...

Description complète

Détails bibliographiques

Auteurs principaux:	Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaçi, Anja Plenske, Pascal Klaus, Thomas Meng
Format:	Artigo
Langue:	Inglês
Publié:	Adis, Springer Healthcare 2024-02-01
Collection:	Rheumatology and Therapy
Sujets:	Axial spondyloarthritis Etanercept Plaque psoriasis Psoriatic arthritis Real world Remission
Accès en ligne:	https://doi.org/10.1007/s40744-023-00633-2
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!